S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)

Fresenius Medical Care (FMS) Earnings Date, Estimates & Call Transcripts

$19.51
+0.12 (+0.62%)
(As of 01:32 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Feb. 20)
$0.47 Beat By $0.11
Consensus EPS
(Feb. 20)
$0.36
Skip Charts & View Estimated and Actual Earnings Data

FMS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FMS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fresenius Medical Care Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.25$0.25$0.25 
Q2 20241$0.41$0.41$0.41 
Q3 20241$0.46$0.46$0.46 
Q4 20241$0.43$0.43$0.43 
FY 20244$1.55$1.55$1.55 
Q1 20251$0.34$0.34$0.34 
Q2 20251$0.45$0.45$0.45 
Q3 20251$0.60$0.60$0.60 
Q4 20251$0.51$0.51$0.51 
FY 20254$1.90$1.90 $1.90

FMS Earnings Date and Information

Fresenius Medical Care last posted its earnings data on February 20th, 2024. The reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.11. The firm earned $5.37 billion during the quarter, compared to analyst estimates of $5.32 billion. Fresenius Medical Care has generated $0.92 earnings per share over the last year ($0.92 diluted earnings per share) and currently has a price-to-earnings ratio of 21.1. Earnings for Fresenius Medical Care are expected to grow by 27.45% in the coming year, from $1.53 to $1.95 per share. Fresenius Medical Care has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Fresenius Medical Care Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
2/20/2024Q4 2023$0.36$0.47+$0.11$0.60$5.32 billion$5.37 billion
11/1/2023Q3 2023$0.37$0.31($0.06)$0.46$5.42 billion$5.37 billion    
8/2/2023Q2 2023$0.24$0.32+$0.08$0.38$5.19 billion$5.25 billion
5/9/2023Q1 2023$0.18$0.28+$0.10$0.40$4.98 billion$5.05 billion
2/21/2023Q4 2022$0.22$0.44+$0.22$0.64$4.85 billion$5.10 billion
10/30/2022Q3 2022$0.37$0.40+$0.03$0.41$4.60 billion$5.14 billion
7/28/2022Q2 2022$0.45$0.41($0.04)$0.55$4.80 billion$5.07 billion
5/4/2022Q1 2022$0.30$0.38+$0.08$0.46$4.97 billion$5.10 billion
2/22/2022Q4 2021$0.50$0.51+$0.01$0.57$5.38 billion$5.31 billion
11/2/2021Q3 2021$0.55$0.55-$0.55$5.37 billion$5.24 billion    
7/30/2021Q2 2021$0.51$0.46($0.05)$0.47$5.33 billion$5.20 billion
5/6/2021Q1 2021$0.47$0.51+$0.04$0.51$5.29 billion$5.07 billion  

Fresenius Medical Care Earnings - Frequently Asked Questions

When is Fresenius Medical Care's earnings date?

Fresenius Medical Care has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on FMS's earnings history.

Did Fresenius Medical Care beat their earnings estimates last quarter?

In the previous quarter, Fresenius Medical Care (NYSE:FMS) reported $0.47 earnings per share (EPS) to beat the analysts' consensus estimate of $0.36 by $0.11. Learn more on analysts' earnings estimate vs. FMS's actual earnings.

How much revenue does Fresenius Medical Care generate each year?

Fresenius Medical Care (NYSE:FMS) has a recorded annual revenue of $21.05 billion.

How much profit does Fresenius Medical Care generate each year?

Fresenius Medical Care (NYSE:FMS) has a recorded net income of $540.07 million. FMS has generated $0.92 earnings per share over the last four quarters.

What is Fresenius Medical Care's price-to-earnings ratio?

Fresenius Medical Care (NYSE:FMS) has a trailing price-to-earnings ratio of 21.07 and a forward price-to-earnings ratio of 12.67. The price/earnings-to-growth ratio is 0.91.

What is Fresenius Medical Care's EPS forecast for next year?

Fresenius Medical Care's earnings are expected to grow from $1.53 per share to $1.95 per share in the next year, which is a 27.45% increase.


More Earnings Resources from MarketBeat

This page (NYSE:FMS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners